Matthew D. Layne, PhD
Associate Professor
Boston University School of Medicine
Dept of Biochemistry

PhD, Boston University School of Medicine



The primary goal of our laboratory is to identify novel pathways that control fibroproliferation with the goal of developing therapeutic inhibitors. Fibroproliferative responses are similar to wound healing processes involving accumulation of contractile myofibroblasts and extracellular matrix (ECM) secretion. Because organ fibrosis, cardiovascular, metabolic/obesity, and cancer pathologies are now recognized to be impacted by fibroblast-myofibroblast differentiation and ECM remodeling our research is examining novel pathways and control mechanisms in these diseases. Central to our studies is determining the function of Aortic carboxypeptidase-like Protein (ACLP), a secreted, collagen-binding protein that enhances fibrosis and myofibroblast differentiation through mechanisms that involve stimulating the transforming growth factor ß (TGFß) receptor signaling complex and controlling mechanical signaling and ECM remodeling.

Active projects in the lab include:
1. Defining the pathways that control vascular adventitial remodeling
2. Inhibiting organ fibrosis through targeting ACLP
3. Developing systems to understand the stomal reaction in breast cancer (in collaboration with the Kirsch lab).
4. Uncovering new mechanisms that control adipose tissue fibrosis (collaboration with Farmer lab).

Graduate Faculty (Primary Mentor of Grad Students)
Boston University School of Medicine, Division of Graduate Medical Sciences


Member of the Cell and Molecular Biology Program
Boston University School of Medicine


Member of the Molecular Medicine Program
Boston University School of Medicine



2011 Fellow of the American Heart Association


Development of Tumor-Directed Therapies
05/01/2015 - 04/30/2018 (PI)
Department of Defense/Army Medical Resea


Role of ACLP in Adipocyte Determination and Fibrosis
01/21/2016 - 03/31/2017 (PI)
Boston Medical Center Corporation NIH NIDDK
P30DK046200

ACLP-mediated Vascular Advential Fibroblast Differentiation and Remodeling
01/01/2014 - 12/31/2016 (PI)
American Heart Association


Inhibitors of Aortic Carboxypeptides-like Proten to Treat Fibroproliferative Diseases
01/01/2015 - 07/02/2016 (PI)
Pfizer, Inc.


Role of ACLP in adipocyte determination and fibrosis
04/01/2012 - 03/31/2014 (PI)
Boston Medical Center Corporation NIH NIDDK
5P30DK046200-20




Yr Title Project-Sub Proj Pubs
2011 Role of ACLP in Vascular Smooth Muscle Biology 5R01HL078869-06 10
2010 Role of ACLP in Vascular Smooth Muscle Biology 5R01HL078869-05 10
2009 Role of ACLP in Vascular Smooth Muscle Biology 3R01HL078869-04S1 10
2009 Role of ACLP in Vascular Smooth Muscle Biology 5R01HL078869-04 10
2008 Role of ACLP in Vascular Smooth Muscle Biology 5R01HL078869-03 10
2007 Role of ACLP in Vascular Smooth Muscle Biology 1R01HL078869-01A2 10
2007 Role of ACLP in Vascular Smooth Muscle Biology 7R01HL078869-02 10
2004 Role of ACLP in dermal wound healing 5K01AR047861-04 4
2003 Role of ACLP in dermal wound healing 5K01AR047861-03 4
2002 Role of ACLP in dermal wound healing 5K01AR047861-02 4
Showing 10 of 13 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Shiwen X, Stratton R, Nikitorowicz-Buniak J, Ahmed-Abdi B, Ponticos M, Denton C, Abraham D, Takahashi A, Suki B, Layne MD, Lafyatis R, Smith BD. A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis. PLoS One. 2015; 10(5):e0126015.View Related Profiles. PMID: 25955164; PMCID: PMC4425676; DOI: 10.1371/journal.pone.0126015;.
  2. McDonald ME, Li C, Bian H, Smith BD, Layne MD, Farmer SR. Myocardin-related transcription factor A regulates conversion of progenitors to beige adipocytes. Cell. 2015 Jan 15; 160(1-2):105-18.View Related Profiles. PMID: 25579684; PMCID: PMC4384505; DOI: 10.1016/j.cell.2014.12.005;.
  3. Xu YX, Ashline D, Liu L, Tassa C, Shaw SY, Ravid K, Layne MD, Reinhold V, Robbins PW. The glycosylation-dependent interaction of perlecan core protein with LDL: implications for atherosclerosis. J Lipid Res. 2015 Feb; 56(2):266-76.View Related Profiles. PMID: 25528754; PMCID: PMC4306681; DOI: 10.1194/jlr.M053017;.
  4. Chen CH, Ho HH, Wu ML, Layne MD, Yet SF. Modulation of cysteine-rich protein 2 expression in vascular injury and atherosclerosis. Mol Biol Rep. 2014 Nov; 41(11):7033-41. PMID: 25034893; DOI: 10.1007/s11033-014-3591-x;.
  5. Wu ML, Chen CH, Lin YT, Jheng YJ, Ho YC, Yang LT, Chen L, Layne MD, Yet SF. Divergent signaling pathways cooperatively regulate TGFß induction of cysteine-rich protein 2 in vascular smooth muscle cells. Cell Commun Signal. 2014; 12:22. PMID: 24674138; PMCID: PMC3973006; DOI: 10.1186/1478-811X-12-22;.
  6. Tumelty KE, Smith BD, Nugent MA, Layne MD. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor ß receptor-dependent and -independent pathways. J Biol Chem. 2014 Jan 31; 289(5):2526-36.View Related Profiles. PMID: 24344132; PMCID: PMC3908388; DOI: 10.1074/jbc.M113.502617;.
  7. Chen CH, Ho YC, Ho HH, Chang IC, Kirsch KH, Chuang YJ, Layne MD, Yet SF. Cysteine-rich protein 2 alters p130Cas localization and inhibits vascular smooth muscle cell migration. Cardiovasc Res. 2013 Dec 1; 100(3):461-71.View Related Profiles. PMID: 23975851; PMCID: PMC3826702; DOI: 10.1093/cvr/cvt207;.
  8. Tumelty KE, Layne MD. Handbook of Proteolytic Enzymes (Rawlings, N. D. and Salvesen, G. S., ed.). Adipocyte Enhancer Binding Protein 1 and Aortic Carboxypeptidase-Like Protein. Academic Press. Oxford. 2013; 1348-1353.
  9. Wang D, Prakash J, Nguyen P, Davis-Dusenbery BN, Hill NS, Layne MD, Hata A, Lagna G. Bone morphogenetic protein signaling in vascular disease: anti-inflammatory action through myocardin-related transcription factor A. J Biol Chem. 2012 Aug 10; 287(33):28067-77. PMID: 22718766; PMCID: PMC3431673; DOI: 10.1074/jbc.M112.379487;.
  10. Wu ML, Layne MD, Yet SF. Heme oxygenase-1 in environmental toxin-induced lung disease. Toxicol Mech Methods. 2012 Jun; 22(5):323-9. PMID: 22394342; DOI: 10.3109/15376516.2012.666685;.
Showing 10 of 67 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 67 publications over 22 distinct years, with a maximum of 9 publications in 2001

YearPublications
19931
19941
19951
19971
19985
19994
20004
20019
20027
20034
20043
20053
20062
20071
20083
20092
20103
20113
20122
20133
20143
20152

My research interests include mechanisms of smooth muscle changes in vascular disease, fibrosis, and now cancer. In a research or laboratory setting I have mentored more than 20 scientists at the undergraduate, graduate, and postdoctoral levels. I have also participated on more 25 PhD dissertation committees. Currently I serve as an academic advisor in the Master's in Medical Sciences (MAMS) program.

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Education Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')


72 E. Concord St Silvio Conte (K)
Boston MA 02118
Google Map


Layne's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department